Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Long Term Investor Alert: Investigation of Potential Wrongdoing
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Sorrento Therapeutics, Inc..
View full press release